Modifiers of mutant huntingtin aggregation

PLoS Currents

Volumn , Issue , 2011, Pages

  Teuling, Eva ^a   Bourgonje, Annika ^a   Veenje, Sven ^a   Thijssen, Karen ^a   de Boer, Jelle ^a   van der Velde, Joeri ^b   Swertz, Morris ^a   Nollen, Ellen ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Groningen Bioinformatics Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATPASE FAMILY GENE 3 LIKE 2; CAENORHABDITIS ELEGANS PROTEIN; ELONGATION FACTOR; HUNTINGTIN; POLYGLUTAMINE; SMALL INTERFERING RNA; TRANSLATION FACTOR; UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; SHORT HAIRPIN RNA;

ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; GENE IDENTIFICATION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC SCREENING; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MODIFIER GENE; MOLECULAR CLONING; NEUROPATHOLOGY; NONHUMAN; PROTEIN AGGREGATION; RNA INTERFERENCE; TRANSLATION INITIATION; CELL STRAIN HEK293; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETIC TRANSFECTION; ORTHOLOGY;

EID: 84867467501     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1255     Document Type: Article

References (45)

1. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE. Selfassembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4604-9. PubMed PMID: 10200309; PubMed Central PMCID: PMC16379.
2. Rosenblatt A, Brinkman RR, Liang KY, Almqvist EW, Margolis RL, Huang CY, Sherr M, Franz ML, Abbott MH, Hayden MR, Ross CA. Familial influence on age of onset among siblings with Huntington disease. Am J Med Genet. 2001 Jul 8;105(5):399-403. PubMed PMID: 11449389.
3. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004 Oct 14;431(7010):805-10. PubMed PMID: 15483602.
4. Sánchez I, Mahlke C, Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature. 2003 Jan 23;421(6921):373-9. PubMed PMID: 12540902.
5. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998 Oct 2;95(1):55-66. PubMed PMID: 9778247.
6. van Ham TJ, Breitling R, Swertz MA, Nollen EA. Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol Med. 2009 Nov;1(8-9):360-70. Review. PubMed PMID: 20049741.
7. Morley JF, Brignull HR, Weyers JJ, Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10417-22. Epub 2002 Jul 16. PubMed PMID: 12122205; PubMed Central PMCID: PMC124929.
8. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI, Plasterk RH. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6403-8. Epub 2004 Apr 14. PubMed PMID: 15084750; PubMed Central PMCID: PMC404057.
9. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998 Jun;19(2):148-54. PubMed PMID: 9620770.
10. Kazemi-Esfarjani P, Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science. 2000 Mar 10;287(5459):1837-40. PubMed PMID: 10710314.
11. Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL, Bonini NM. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet. 1999 Dec;23(4):425-8. PubMed PMID: 10581028.
12. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J. Identification of genes that modify ataxin- 1-induced neurodegeneration. Nature. 2000 Nov 2;408(6808):101-6. PubMed PMID: 11081516.
13. Kitamura A, Kubota H, Pack CG, Matsumoto G, Hirayama S, Takahashi Y, Kimura H, Kinjo M, Morimoto RI, Nagata K. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol. 2006 Oct;8(10):1163-70. Epub 2006 Sep 17. PubMed PMID: 16980958.
14. Tam S, Geller R, Spiess C, Frydman J. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol. 2006 Oct;8(10):1155-62. Epub 2006 Sep 17. PubMed PMID: 16980959; PubMed Central PMCID: PMC2829982.
15. van Ham TJ, Holmberg MA, van der Goot AT, Teuling E, Garcia-Arencibia M, Kim HE, Du D, Thijssen KL, Wiersma M, Burggraaff R, van Bergeijk P, van Rheenen J, Jerre van Veluw G, Hofstra RM, Rubinsztein DC, Nollen EA. Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell. 2010 Aug 20;142(4):601-12. PubMed PMID: 20723760.
16. Wyttenbach A, Carmichael J, Swartz J, Furlong RA, Narain Y, Rankin J, Rubinsztein DC. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2898-903. PubMed PMID: 10717003; PubMed Central PMCID: PMC16027.
17. Bernards R, Brummelkamp TR, Beijersbergen RL. shRNA libraries and their use in cancer genetics. Nat Methods. 2006 Sep;3(9):701-6. Review. PubMed PMID: 16929315.
18. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature. 2004 Mar 25;428(6981):431-7. PubMed PMID: 15042092.
19. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002 Apr 19;296(5567):550-3. Epub 2002 Mar 21. PubMed PMID: 11910072.
20. Behrends C, Langer CA, Boteva R, Böttcher UM, Stemp MJ, Schaffar G, Rao BV, Giese A, Kretzschmar H, Siegers K, Hartl FU. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol Cell. 2006 Sep 15;23(6):887-97. PubMed PMID: 16973440.
21. Liu Q, Fischer U, Wang F, Dreyfuss G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell. 1997 Sep 19;90(6):1013-21. PubMed PMID: 9323129.
22. Li X, Wang CE, Huang S, Xu X, Li XJ, Li H, Li S. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Hum Mol Genet. 2010 Jun 15;19(12):2445-55. Epub 2010 Mar 30. PubMed PMID: 20354076; PubMed Central PMCID: PMC2876889.
23. Li XJ, Li S. Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis. 2010 Dec 8. [Epub ahead of print] PubMed PMID: 21145396.
24. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997 Sep 26;277(5334):1990-3. PubMed PMID: 9302293.
25. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci. 1999 Apr 1;19(7):2522-34. PubMed PMID: 10087066.
26. Venkatraman P, Wetzel R, Tanaka M, Nukina N, Goldberg AL. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell. 2004 Apr 9;14(1):95-104. PubMed PMID: 15068806.
27. Michalik A, Van Broeckhoven C. Proteasome degrades soluble expanded polyglutamine completely and efficiently. Neurobiol Dis. 2004 Jun;16(1):202-11. PubMed PMID: 15207277.
28. Díaz-Hernández M, Hernández F, Martín-Aparicio E, Gómez-Ramos P, Morán MA, Castaño JG, Ferrer I, Avila J, Lucas JJ. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci. 2003 Dec 17;23(37):11653-61. PubMed PMID: 14684867.
29. Bett JS, Goellner GM, Woodman B, Pratt G, Rechsteiner M, Bates GP. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target. Hum Mol Genet. 2006 Jan 1;15(1):33-44. Epub 2005 Nov 25. Erratum in: Hum Mol Genet. 2006 Feb 15;15(4):665. PubMed PMID: 16311253.
30. Wang J, Wang CE, Orr A, Tydlacka S, Li SH, Li XJ. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J Cell Biol. 2008 Mar 24;180(6):1177-89. PubMed PMID: 18362179; PubMed Central PMCID: PMC2290845.
31. Bennett EJ, Shaler TA, Woodman B, Ryu KY, Zaitseva TS, Becker CH, Bates GP, Schulman H, Kopito RR. Global changes to the ubiquitin system in Huntington's disease. Nature. 2007 Aug 9;448(7154):704-8. PubMed PMID: 17687326.
32. Ramser J, Ahearn ME, Lenski C, Yariz KO, Hellebrand H, von Rhein M, Clark RD, Schmutzler RK, Lichtner P, Hoffman EP, Meindl A, Baumbach-Reardon L. Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. Am J Hum Genet. 2008 Jan;82(1):188-93. PubMed PMID: 18179898; PubMed Central PMCID: PMC2253959.
33. Bett JS, Benn CL, Ryu KY, Kopito RR, Bates GP. The polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease. J Cell Mol Med. 2009 Aug;13(8B):2645-57. PubMed PMID: 19602042; PubMed Central PMCID: PMC2892477.
34. Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, Finardi A, Cagnoli C, Tempia F, Frontali M, Veneziano L, Sacco T, Boda E, Brussino A, Bonn F, Castellotti B, Baratta S, Mariotti C, Gellera C, Fracasso V, Magri S, Langer T, Plevani P, Di Donato S, Muzi-Falconi M, Taroni F. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet. 2010 Apr;42(4):313-21. Epub 2010 Mar 7. PubMed PMID: 20208537.
35. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Dürr A, Fontaine B, Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell. 1998 Jun 12;93(6):973-83. PubMed PMID: 9635427.
36. Duvezin-Caubet S, Koppen M, Wagener J, Zick M, Israel L, Bernacchia A, Jagasia R, Rugarli EI, Imhof A, Neupert W, Langer T, Reichert AS. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol Biol Cell. 2007 Sep;18(9):3582-90. Epub 2007 Jul 5. PubMed PMID: 17615298; PubMed Central PMCID: PMC1951777.
37. Duvezin-Caubet S, Koppen M, Wagener J, Zick M, Israel L, Bernacchia A, Jagasia R, Rugarli EI, Imhof A, Neupert W, Langer T, Reichert AS. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol Biol Cell. 2007 Sep;18(9):3582-90. Epub 2007 Jul 5. PubMed PMID: 17615298; PubMed Central PMCID: PMC1951777.
38. Koppen M, Metodiev MD, Casari G, Rugarli EI, Langer T. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol Cell Biol. 2007 Jan;27(2):758-67. Epub 2006 Nov 13. PubMed PMID: 17101804; PubMed Central PMCID: PMC1800790.
39. Carra S, Brunsting JF, Lambert H, Landry J, Kampinga HH. HspB8 participates in protein quality control by a non-chaperone-like mechanism that requires eIF2{alpha} phosphorylation. J Biol Chem. 2009 Feb 27;284(9):5523-32. Epub 2008 Dec 29. PubMed PMID: 19114712.
40. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol. 2009 Apr;174(4):1241-51. Epub 2009 Mar 5. PubMed PMID: 19264902; PubMed Central PMCID: PMC2671357.
41. Zhao C, Bellur DL, Lu S, Zhao F, Grassi MA, Bowne SJ, Sullivan LS, Daiger SP, Chen LJ, Pang CP, Zhao K, Staley JP, Larsson C. Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs. Am J Hum Genet. 2009 Nov;85(5):617-27. Epub 2009 Oct 29. PubMed PMID: 19878916; PubMed Central PMCID: PMC2775825.
42. Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, Davisson MT, Sundberg JP, Schimmel P, Ackerman SL. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature. 2006 Sep 7;443(7107):50-5. Epub 2006 Aug 13. PubMed PMID: 16906134.
43. Todd PK, Paulson HL. RNA-mediated neurodegeneration in repeat expansion disorders. Ann Neurol. 2010 Mar;67(3):291-300. Review. PubMed PMID: 20373340; PubMed Central PMCID: PMC2852186.
44. Doumanis J, Wada K, Kino Y, Moore AW, Nukina N. RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS One. 2009 Sep 30;4(9):e7275. PubMed PMID: 19789644; PubMed Central PMCID: PMC2748703.
45. Zhang S, Binari R, Zhou R, Perrimon N. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics. 2010 Apr;184(4):1165-79. Epub 2010 Jan 25. PubMed PMID: 20100940; PubMed Central PMCID: PMC2865916.